Research Summary
Gastroesophageal Reflux Disease (GERD) drugs and devices refer to pharmaceuticals and medical devices designed to manage and treat the symptoms and complications of GERD, a chronic condition where stomach acid frequently flows back into the esophagus, causing irritation and inflammation. GERD drugs commonly include proton pump inhibitors (PPIs) and H2 blockers, which reduce the production of stomach acid to alleviate symptoms like heartburn and regurgitation. Antacids may also be used for short-term relief. GERD devices can include antireflux barriers or surgical interventions aimed at preventing the backflow of stomach acid into the esophagus. These may include devices like the LINX Reflux Management System, a magnetic sphincter augmentation device. The development and use of drugs and devices for GERD aim to improve the quality of life for individuals suffering from this condition by managing symptoms and preventing complications such as esophageal damage and Barrett＇s esophagus.
According to WENKH research statistics, the global Gastro Esophageal Reflux Disease Drug and Devices market size will reach 6,813.68 Million USD in 2025 and is projected to reach 8,193.82 Million USD by 2032, with a CAGR of 2.67% (2025-2032). Among them, the Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices market is undergoing rapid changes, reaching Million USD in 2025, accounting for approximately % of the global market share. It is projected to reach Million USD by 2032.
The competitive landscape of the Gastro Esophageal Reflux Disease Drug and Devices market is currently being shaped by the fierce rivalry among a few key players. Companies such as Endogastric Solutions, Medigus, and Medtronic are playing a leading role by continuously launching innovative products and forging strategic collaborations to expand their presence. Rather than focusing solely on symptom relief, these companies are increasingly exploring long-term disease management solutions, which in turn is driving market evolution through differentiated technologies and value-added services. The integration of personalized treatment strategies with digital monitoring tools has also become a core approach to enhancing product competitiveness.
At the same time, growing demand for non-invasive therapies is accelerating investment in endoscopic technologies and minimally invasive devices. These tools are gaining widespread attention for their shorter recovery times and reduced side effects, significantly improving patient experience. This shift is also influencing regulatory policies and shaping how healthcare institutions choose their treatment protocols. As new players continue to enter the market with novel drug formulations and intelligent device interfaces, the industry is becoming increasingly diverse and dynamic, offering patients a broader range of treatment options that align more closely with their individual needs.
The global Gastro Esophageal Reflux Disease Drug and Devices market is highly competitive, with key market players including Endogastric Solutions, Medigus, Medtronic, Johnson & Johnson, Carbon Medical technologies, etc. This report categorizes the competitive landscape of the global Gastro Esophageal Reflux Disease Drug and Devices market into three tiers based on annual revenue, with the top three market players holding approximately % of the total market share.
This report provides an in-depth analysis of the global Gastro Esophageal Reflux Disease Drug and Devices market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, sales revenue, and gross profit margin of major players in the global Gastro Esophageal Reflux Disease Drug and Devices industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different product segments of Gastro Esophageal Reflux Disease Drug and Devices and their downstream application fields.
In terms of data, this report includes a comprehensive time-series dataset. The historical data spans from 2020 to 2024, providing a solid foundation for analyzing past market trends. The year 2025 is used as a base year to accurately assess the current market landscape. Forecast data covers the period from 2026 to 2032, utilizing scientific analysis methods and models to offer forward-looking predictions and insights into the market's future development. This provides valuable reference information for industry participants and stakeholders.
The report covers regions and countries including North America, Europe, China, Asia Pacific (excluding China), Latin America, the Middle East, and Africa. It particularly focuses on the sales revenue of Gastro Esophageal Reflux Disease Drug and Devices in these regions and countries, as well as the market share of key market players in each region. The report provides an in-depth analysis of the regional distribution and future development trends of the Gastro Esophageal Reflux Disease Drug and Devices market. By considering local policies, this report evaluates the market prospects of Gastro Esophageal Reflux Disease Drug and Devices in each region and country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.
This report places a strong emphasis on data quality and reliability, utilizing diverse and extensive data sources to ensure the accuracy and validity of the information presented. Primary data collection involves multiple channels, including in-depth interviews with senior executives, industry experts, supply chain stakeholders, and end consumers. These interviews provide key insights into corporate strategic planning, industry policy interpretation, supply chain dynamics, and end-user experiences. Secondary data sources cover a wide range of authoritative statistics from government agencies, customs databases, industry associations, third-party paid databases, brokerage research reports, academic research findings, corporate annual reports, financial statements, real-time news updates, and relevant information from international organizations. These data sources serve as a solid foundation for verification and analysis.
Companies Covered
Endogastric Solutions
Medigus
Medtronic
Johnson & Johnson
Carbon Medical technologies
Product Segment
Drugs
Devices
Product Application
Drugs Treatment
Surgical Treatment
Minimally Invasive Treatment
Chapter Scope
Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects
Chapter 2: Global Gastro Esophageal Reflux Disease Drug and Devices Industry Chain Analysis
Chapter 3: Global Gastro Esophageal Reflux Disease Drug and Devices Industry Environment Analysis and Porter's Five Forces Analysis
Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Gastro Esophageal Reflux Disease Drug and Devices Market (Market Share, Product Revenue Comparison, Tier Division, Corporate Expansion and M&A Trends)
Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Features and Product Segment, Product Revenue, Product Average Price, Gross Profit Margin and Geographical Sales Share)
Chapter 6: Global Gastro Esophageal Reflux Disease Drug and Devices Product Segment and Downstream Application Size Analysis and Major Regional Market Size Analysis
Chapter 7: North America Gastro Esophageal Reflux Disease Drug and Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 8: Europe Gastro Esophageal Reflux Disease Drug and Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 9: China Gastro Esophageal Reflux Disease Drug and Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 10: Asia Pacific (excluding China) Gastro Esophageal Reflux Disease Drug and Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 11: Latin America Gastro Esophageal Reflux Disease Drug and Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 12: Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 13: Research Conclusion
Chapter 14: Methodology and Data Source
Purpose and Value of the Report
Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.
Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.
Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.
Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.
Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.
Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.
Table of Contents
1 Gastro Esophageal Reflux Disease Drug and Devices Market Overview
1.1 Product Definition Introduction
1.2 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Forecast Analysis (2020-2032)
1.3 Gastro Esophageal Reflux Disease Drug and Devices Market Status and Development Prospects
1.3.1 Gastro Esophageal Reflux Disease Drug and Devices Market Status
1.3.2 Gastro Esophageal Reflux Disease Drug and Devices Industry Development Prospects
1.4 Gastro Esophageal Reflux Disease Drug and Devices Market Overview by Product Segment
1.4.1 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Forecast Analysis by Product Segment: 2020 VS 2025 VS 2032
1.4.2 Drugs
1.4.3 Devices
1.5 Gastro Esophageal Reflux Disease Drug and Devices Market Overview by Product Application
1.5.1 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Forecast Analysis by Product Application: 2020 VS 2025 VS 2032
1.5.2 Drugs Treatment
1.5.3 Surgical Treatment
1.5.4 Minimally Invasive Treatment
2 Gastro Esophageal Reflux Disease Drug and Devices Industry Supply Chain Analysis
2.1 Gastro Esophageal Reflux Disease Drug and Devices Supply Chain
2.2 Gastro Esophageal Reflux Disease Drug and Devices Midstream Suppliers
2.3 Gastro Esophageal Reflux Disease Drug and Devices Downstream Customers
2.4 Gastro Esophageal Reflux Disease Drug and Devices Sales Channel Analysis
3 Gastro Esophageal Reflux Disease Drug and Devices Market Environment Analysis
3.1 Gastro Esophageal Reflux Disease Drug and Devices Industry Policy Analysis
3.2 Gastro Esophageal Reflux Disease Drug and Devices Emerging Technology Trends in the Industry
3.3 Gastro Esophageal Reflux Disease Drug and Devices Restraining Factors Analysis
3.4 Gastro Esophageal Reflux Disease Drug and Devices Market Porter's Five Forces Analysis
3.4.1 Competitive Rivalry
3.4.2 Threat of New Entrants
3.4.3 Bargaining Power of Suppliers
3.4.4 Bargaining Power of Buyers
3.4.5 Threat of Substitute Products or Services
4 Global Gastro Esophageal Reflux Disease Drug and Devices Market Players Competition Landscape
4.1 Global Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Key Players (2021-2025)
4.2 Global Gastro Esophageal Reflux Disease Drug and Devices Market Position by Key Players
4.3 Global Key Players Headquarter and Key Area Served
4.4 Global Gastro Esophageal Reflux Disease Drug and Devices Market Expansion and M&A Dynamic
5 In-depth Analysis of Key Players
5.1 Endogastric Solutions
5.1.1 Endogastric Solutions Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.1.2 Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Product Features
5.1.3 Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Product Revenue and Gross Margin Analysis (2021-2025)
5.1.4 Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Revenue by Product Segment
5.1.5 Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region
5.2 Medigus
5.2.1 Medigus Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.2.2 Medigus Gastro Esophageal Reflux Disease Drug and Devices Product Features
5.2.3 Medigus Gastro Esophageal Reflux Disease Drug and Devices Product Revenue and Gross Margin Analysis (2021-2025)
5.2.4 Medigus Gastro Esophageal Reflux Disease Drug and Devices Revenue by Product Segment
5.2.5 Medigus Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region
5.3 Medtronic
5.3.1 Medtronic Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.3.2 Medtronic Gastro Esophageal Reflux Disease Drug and Devices Product Features
5.3.3 Medtronic Gastro Esophageal Reflux Disease Drug and Devices Product Revenue and Gross Margin Analysis (2021-2025)
5.3.4 Medtronic Gastro Esophageal Reflux Disease Drug and Devices Revenue by Product Segment
5.3.5 Medtronic Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.4.2 Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Product Features
5.4.3 Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Product Revenue and Gross Margin Analysis (2021-2025)
5.4.4 Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Revenue by Product Segment
5.4.5 Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region
5.5 Carbon Medical technologies
5.5.1 Carbon Medical technologies Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.5.2 Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Product Features
5.5.3 Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Product Revenue and Gross Margin Analysis (2021-2025)
5.5.4 Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Revenue by Product Segment
5.5.5 Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region
6 Global Gastro Esophageal Reflux Disease Drug and Devices Market Analysis by Regions, by Product Segment and Application
6.1 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Forecast by Region: 2020 VS 2025 VS 2032
6.1.1 Global Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Region (2020-2025)
6.1.2 Global Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Region (2026-2032)
6.2 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size by Product Segment (2020-2032)
6.3 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size by Product Application (2020-2032)
7 North America Gastro Esophageal Reflux Disease Drug and Devices Market Analysis
7.1 North America Gastro Esophageal Reflux Disease Drug and Devices Market Prospects
7.1.1 North America Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Growth Forecast by Countries (2020-2032)
7.1.2 U.S.
7.1.3 Canada
7.2 North America Gastro Esophageal Reflux Disease Drug and Devices Market Size by Product Segment (2020-2032)
7.3 North America Gastro Esophageal Reflux Disease Drug and Devices Market Size by Product Application (2020-2032)
8 Europe Gastro Esophageal Reflux Disease Drug and Devices Market Analysis
8.1 Europe Gastro Esophageal Reflux Disease Drug and Devices Market Prospects
8.1.1 Europe Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Growth Forecast by Countries (2020-2032)
8.1.2 Germany
8.1.3 France
8.1.4 United Kingdom
8.1.5 Italy
8.1.6 Spain
8.1.7 Benelux
8.2 Europe Gastro Esophageal Reflux Disease Drug and Devices Market Size by Product Segment (2020-2032)
8.3 Europe Gastro Esophageal Reflux Disease Drug and Devices Market Size by Product Application (2020-2032)
9 China Gastro Esophageal Reflux Disease Drug and Devices Market Analysis
9.1 China Gastro Esophageal Reflux Disease Drug and Devices Market Prospects
9.2 China Gastro Esophageal Reflux Disease Drug and Devices Market Size by Product Segment (2020-2032)
9.3 China Gastro Esophageal Reflux Disease Drug and Devices Market Size by Product Application (2020-2032)
10 Asia Pacific (excl. China) Gastro Esophageal Reflux Disease Drug and Devices Market Analysis
10.1 Asia Pacific (excl. China) Gastro Esophageal Reflux Disease Drug and Devices Market Prospects
10.1.1 Asia Pacific (excl. China) Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Forecast by Countries (2020-2032)
10.1.2 Japan
10.1.3 South Korea
10.1.4 India
10.1.5 Southeast Asia
10.1.6 Australia
10.2 Asia Pacific (excl. China) Gastro Esophageal Reflux Disease Drug and Devices Market Size by Product Segment (2020-2032)
10.3 Asia Pacific (excl. China) Gastro Esophageal Reflux Disease Drug and Devices Market Size by Product Application (2020-2032)
11 Latin America Gastro Esophageal Reflux Disease Drug and Devices Market Analysis
11.1 Latin America Gastro Esophageal Reflux Disease Drug and Devices Market Prospects
11.1.1 Latin America Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Forecast by Countries (2020-2032)
11.1.2 Mexico
11.1.3 Brazil
11.2 Latin America Gastro Esophageal Reflux Disease Drug and Devices Market Size by Product Segment (2020-2032)
11.3 Latin America Gastro Esophageal Reflux Disease Drug and Devices Market Size by Product Application (2020-2032)
12 Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Market Analysis
12.1 Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Market Prospects
12.1.1 Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Forecast by Countries (2020-2032)
12.1.2 Saudi Arabia
12.1.3 South Africa
12.2 Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Market Size by Product Segment (2020-2032)
12.3 Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Market Size by Product Application (2020-2032)
13 Research Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.2 Research Landscape
14.3 Research Benchmark and Hypothesis
14.4 Data Source
14.4.1 Primary Sources
14.4.2 Secondary Sources
14.5 Data Cross Validation
14.6 Disclaimer
Table 1：Global Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Forecast Analysis by Product Segment (2020 VS 2025 VS 2032) & (Million USD)
Table 2：Global Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Forecast Analysis by Product Application (2020 VS 2025 VS 2032) & (Million USD)
Table 3：Gastro Esophageal Reflux Disease Drug and Devices Downstream Customers List
Table 4：Gastro Esophageal Reflux Disease Drug and Devices Distributors/Dealers List
Table 5：Global Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Key Players (2021-2025) & (Million USD)
Table 6：Global Gastro Esophageal Reflux Disease Drug and Devices Market Position by Key Players
Table 7：Global Key Players Headquarter and Key Area Served
Table 8：Global Gastro Esophageal Reflux Disease Drug and Devices Market Expansion and M&A Dynamic
Table 9：Endogastric Solutions Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 10：Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Product Features
Table 11：Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Revenue (Million USD) and Gross Margin (2021-2025)
Table 12：Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Revenue by Product Segment
Table 13：Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region
Table 14：Medigus Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 15：Medigus Gastro Esophageal Reflux Disease Drug and Devices Product Features
Table 16：Medigus Gastro Esophageal Reflux Disease Drug and Devices Revenue (Million USD) and Gross Margin (2021-2025)
Table 17：Medigus Gastro Esophageal Reflux Disease Drug and Devices Revenue by Product Segment
Table 18：Medigus Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region
Table 19：Medtronic Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 20：Medtronic Gastro Esophageal Reflux Disease Drug and Devices Product Features
Table 21：Medtronic Gastro Esophageal Reflux Disease Drug and Devices Revenue (Million USD) and Gross Margin (2021-2025)
Table 22：Medtronic Gastro Esophageal Reflux Disease Drug and Devices Revenue by Product Segment
Table 23：Medtronic Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region
Table 24：Johnson & Johnson Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 25：Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Product Features
Table 26：Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Revenue (Million USD) and Gross Margin (2021-2025)
Table 27：Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Revenue by Product Segment
Table 28：Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region
Table 29：Carbon Medical technologies Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 30：Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Product Features
Table 31：Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Revenue (Million USD) and Gross Margin (2021-2025)
Table 32：Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Revenue by Product Segment
Table 33：Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Revenue by Region
Table 34：Global Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Forecast by Region (2020 VS 2025 VS 2032) & (Million USD)
Table 35：Global Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Region (2020-2025) & (Million USD)
Table 36：Global Gastro Esophageal Reflux Disease Drug and Devices Market Share by Region (2020-2025)
Table 37：Global Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Region (2026-2032) & (Million USD)
Table 38：Global Gastro Esophageal Reflux Disease Drug and Devices Market Share Forecast by Region (2026-2032)
Table 39：Global Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 40：Global Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 41：Global Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Product Application (2020-2025) & (Million USD)
Table 42：Global Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 43：North America Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Countries (2020-2025) & (Million USD)
Table 44：North AmericaGastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 45：North America Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 46：North America Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 47：North America Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Product Application (2020-2025) & (Million USD)
Table 48：North America Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 49：Europe Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Countries (2020-2025) & (Million USD)
Table 50：Europe Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 51：Europe Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 52：Europe Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 53：Europe Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Product Application (2020-2025) & (Million USD)
Table 54：Europe Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 55：China Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 56：China Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 57：China Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Product Application (2020-2025) & (Million USD)
Table 58：China Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 59：Asia Pacific (excl. China) Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Countries (2020-2025) & (Million USD)
Table 60：Asia Pacific (excl. China) Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 61：Asia Pacific (excl. China) Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 62：Asia Pacific (excl. China) Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 63：Asia Pacific (excl. China) Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Product Application (2020-2025) & (Million USD)
Table 64：Asia Pacific (excl. China) Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 65：Latin America Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Countries (2020-2025) & (Million USD)
Table 66：Latin America Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 67：Latin America Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 68：Latin America Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 69：Latin America Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Product Application (2020-2025) & (Million USD)
Table 70：Latin America Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 71：Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Countries (2020-2025) & (Million USD)
Table 72：Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 73：Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 74：Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 75：Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Product Application (2020-2025) & (Million USD)
Table 76：Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 77：Secondary Sources
Figure 1：Gastro Esophageal Reflux Disease Drug and Devices Product Scope
Figure 2：Global Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Forecast Analysis (2020-2032) & (Million USD)
Figure 3：Global Gastro Esophageal Reflux Disease Drug and Devices Product Segment Market Share (2025 & 2032)
Figure 4：Global Gastro Esophageal Reflux Disease Drug and Devices Product Application Market Share (2025 & 2032)
Figure 5：Drugs Product Scope
Figure 6：Devices Product Scope
Figure 7：Drugs Treatment Product Scope
Figure 8：Surgical Treatment Product Scope
Figure 9：Minimally Invasive Treatment Product Scope
Figure 10：Gastro Esophageal Reflux Disease Drug and Devices Industrial Chain Framework
Figure 11：Global Gastro Esophageal Reflux Disease Drug and Devices Market by Geographic Segmentation in 2025
Figure 12：Global Gastro Esophageal Reflux Disease Drug and Devices Market Share by Region (2020 VS 2025)
Figure 13：North America Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 14：North America Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Countries (2025 VS 2032)
Figure 15：U.S. Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 16：Canada Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 17：Europe Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 18：Europe Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Countries (2025 VS 2032)
Figure 19：Germany Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 20：France Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 21：United Kingdom Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 22：Italy Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 23：Spain Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 24：Benelux Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 25：China Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 26：Asia Pacific (excl. China) Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 27：Asia Pacific (excl. China) Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Countries (2025 VS 2032)
Figure 28：Japan Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 29：South Korea Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 30：India Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 31：Southeast Asia Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 32：Australia Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 33：Latin America Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 34：Latin America Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Countries (2025 VS 2032)
Figure 35：Mexico Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 36：Brazil Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 37：Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 38：Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Countries (2025 VS 2032)
Figure 39：Saudi Arabia Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 40：South Africa Gastro Esophageal Reflux Disease Drug and Devices Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 41：Research Methodology
Figure 42：Primary Sources
Figure 43：Data Cross Validation
English
Related Reports 
